News

In the News

In partnership with our network partners, together, we have shared research on real-world treatment patterns in breast and non-small cell lung cancer.

Hero News

Events

Podcast

Understanding the complexities of treating patients with Myelodysplastic Syndrome

December 09, 2022

Dr. Garcia-Manero joins Molly Scannell Bryan to share his experience in managing patients with MDS, the important nuances in treating patients with this diagnosis, and the role real-world data can play in improving care.

Webinar

Practical Considerations When Generating RWE in Oncology: What Does Best-in-Class Look Like?

December 05, 2022

With growing regulatory, payer, and provider acceptance, real world evidence (RWE) continues to generate insights on the usage, safety, risks, and benefits of cancer treatment collected in standard clinical practice, especially from electronic medical records. As these types of data continue to be used for mandated safety studies, innovative study designs such as external comparator arm studies, and HEOR studies with payers and providers, it is important to understand the strengths and limitations of the data to draw the right conclusions. Join us for this webinar covering oncology care in the United States. Experts will discuss gaps in real world databases and identify solutions to address these limitations.

Podcast

Treating Prostate Cancer: A patient-centric approach to improving outcomes

December 09, 2022

Dr. Christopher Logothetis joins Dr. Amol Bhalla to share the advances he’s been able to witness and help create, why we need meaningful real-world data that includes the patient perspective, and what steps we can collectively take to usher in the future of medicine.

Podcast

Treating Breast Cancer with testing, therapies, clinical trials and real-world data

December 09, 2022

Dr. Vicente Valero joins Dr. Anna Berry to discuss how he navigates testing, treatments, and using clinical trials along with real-world data to power decision-making to improve patient care.

Podcast

Treating Non-Small Cell Lung Cancer: Evolution from Chemotherapy to Targeted Therapies

December 09, 2022

Drs. George Simon and Matt Rioth talk about how gaining access to molecular information transformed the practice of medicine, effectively navigating the complexities of clinical trials, and using real-world data to guide treatment decision-making.

Webinar

Syapse Real-World Dialogue: Advancing Patient Care through Real-World Data, Machine Learning, and Systems Biology

September 21, 2022

It’s estimated that less than 5% of adult cancer patients enroll in clinical trials. Due to clinical trial eligibility criteria and access barriers to clinical trials, it is assumed that clinical trial results and the derived clinical evidence have limited generalizability. This creates a gap in needed data and evidence for development of novel therapeutics that will benefit the greatest number of patients, and has most certainly contributed to health care disparities. The next installment of “Real-World Dialogues” will focus on leveraging real-world data, machine learning, and systems biology to enable drug target discovery, drug repurposing, combinatorial therapeutics, and, ultimately, creating evidence to power life-saving decisions for patients and their families.

Webinar

The path to revolutionized cancer care: Accessing data to rapidly generate patient insights to impact care

March 10, 2022

Cancer Care is being revolutionized with real-world data, which tells a comprehensive story for cancer patients. Oncology and technology leaders are always searching for creative approaches to reduce the complexity of exchanging data across multiple platforms. However, when making a sizable investment in getting access to the data you need to inform clinical decision-making, it’s essential to have an engine that can provide out–of–the–box capabilities and the flexibility to manage customizations. In this fireside chat, health-tech experts from Syapse and Infor will discuss the benefits of working in tandem to streamline oncology data acquisition to improve outcomes for cancer patients.

News

11/03/2022

Connecting Health Systems and Life Science Researchers To Maximize the Potential of Real-world Evidence.

By Tiffany Druley

There needs to be a bigger emphasis and move towards connecting the life science companies who are doing the work of using biomarkers to develop therapies with the health systems where a majority of cancer care in the US actually occurs. Not enough patients are getting the benefit of precision medicine today. It starts with data sharing and real world evidence.

Read

04/21/2022

Using NLP Technology To Uncover Real-World Patient Insights

By Tiffany Druley

It’s estimated that humans create a combined 2.5 quintillion bytes of data each day – and that around 90% of all data to ever exist was created in just the last few years.

Read

01/13/2022

Dr. Ali on the Need to Understand Real-World Disparities in BRCA Testing in TNBC

By Tiffany Druley

During the 2021 San Antonio Breast Cancer Symposium, findings from a real-world analysis evaluating racial disparities in BRCA testing for patients with TNBC were presented in a virtual poster. The results showed that the rate of BRCA testing was high overall in evaluated patients with TNBC, although a larger proportion of White patients received testing compared with Black or African American patients.

Read

Load more

Press Releases

09/15/2022

Syapse Enters Collaboration with Merck Using Real-World Evidence to Better Understand Cancers

By Devon Hellman

SAN FRANCISCO, NEW YORK, September 15, 2022 — Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, has entered a collaboration with Merck, known as MSD, outside the United States and Canada, to leverage Syapse’s leading real-world evidence solutions designed to improve outcomes for cancer patients.

Read

08/31/2022

Syapse and Genesis Research Combine Forces to Offer Real-World Evidence Services and Data to Oncology Innovators

By Chris Burkhardt

SAN FRANCISCO, August 30, 2022 — Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, today announced that they have entered into a strategic partnership with Genesis Research, combining the expertise and resources of both companies to better serve clients developing new oncology innovations.

Read

08/18/2022

Science 37 and Syapse Partner to Enable Faster Patient Enrollment in Oncology Clinical Trials

By Tiffany Druley

RESEARCH TRIANGLE PARK and SAN FRANCISCO, August 18, 2022 — Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, and Syapse®, a leading real-world evidence company, today announced a partnership to deploy proprietary real-world data intelligence and analytics that will help identify suitable patients for o…

Read

Load more

Let's chat.

If you’d like to learn more about Syapse, tell us a little about yourself and we will reach out as soon as possible.